Axinn partner Chad Landmon co-authored, "FDA Announces Major Generic Drug Labeling Changes In the Wake of Preemption Decisions Involving Generic Drug Product Liability," which was featured in the Novmeber 21, 2013 edition of Corporate Compliance Insights.